AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 101 filers reported holding AVROBIO INC in Q1 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | -80.0% | 1,333 | -73.0% | 0.00% | – |
Q2 2022 | $5,000 | +150.0% | 4,928 | +296.8% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 1,242 | +148.4% | 0.00% | – |
Q4 2021 | $2,000 | -99.6% | 500 | -99.4% | 0.00% | – |
Q3 2021 | $468,000 | -48.3% | 83,837 | -17.8% | 0.00% | – |
Q2 2021 | $906,000 | -74.0% | 101,954 | -62.9% | 0.00% | – |
Q1 2021 | $3,490,000 | -55.9% | 275,054 | -51.5% | 0.00% | -100.0% |
Q4 2020 | $7,910,000 | +34.7% | 567,454 | +25.8% | 0.00% | 0.0% |
Q3 2020 | $5,874,000 | -56.7% | 451,154 | -41.9% | 0.00% | 0.0% |
Q2 2020 | $13,553,000 | +12.1% | 776,654 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $12,085,000 | +173.9% | 776,654 | +254.4% | 0.00% | – |
Q4 2019 | $4,412,000 | +159.4% | 219,170 | +82.0% | 0.00% | – |
Q3 2019 | $1,701,000 | -76.2% | 120,443 | -12.7% | 0.00% | -100.0% |
Q3 2018 | $7,153,000 | -49.9% | 137,900 | -72.4% | 0.00% | -50.0% |
Q2 2018 | $14,280,000 | – | 500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
Western Standard LLC | 310,361 | $477,956 | 0.43% |
Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |